# A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice

> **NCT02740218** · — · COMPLETED · sponsor: **Amgen** · enrollment: 610 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **OTHER:** Patient questionnaire

## Key facts

- **NCT ID:** NCT02740218
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06-30
- **Primary completion:** 2021-10-27
- **Final completion:** 2021-10-27
- **Target enrollment:** 610 (ACTUAL)
- **Last updated:** 2024-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02740218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02740218, "A Study of Real-World Experience of Psoriasis Patients Treated With Apremilast in Clinical Dermatology Practice". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02740218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*